NovaBridge Biosciences (FRA:0VY) FCF Margin %: 0.00% (As of Dec. 2025)


FRA:0VY NovaBridge Biosciences FRA:0VY
30 GF Score
Price €1.38
! 2 Warning Signs
View Full Analysis

What is NovaBridge Biosciences FCF Margin %?

NovaBridge Biosciences FRA:0VY -1.43% 30 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:0VY with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 958 Biotechnology companies, NovaBridge Biosciences ranks worse than 104384.03% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. NovaBridge Biosciences's Free Cash Flow for the three months ended in Dec. 2025 was €0.00 Mil. NovaBridge Biosciences's Revenue for the three months ended in Dec. 2025 was €0.00 Mil. Therefore, NovaBridge Biosciences's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, NovaBridge Biosciences's current FCF Yield % is -10.83%.

The historical rank and industry rank for NovaBridge Biosciences's FCF Margin % or its related term are showing as below:


During the past 9 years, the highest FCF Margin % of NovaBridge Biosciences was 3331.59%. The lowest was -11528.64%. And the median was -1139.46%.

FRA:0VY's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

NovaBridge Biosciences FCF Margin % Related Terms

NovaBridge Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for NovaBridge Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovaBridge Biosciences FCF Margin % Chart

NovaBridge Biosciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only -1,139.45 3,331.90 -11,519.48 0.00 0.00

NovaBridge Biosciences Quarterly Data
Sep19 Dec19 Jun20 Sep20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:0VY vs ELTX, CNTN, INDP: FCF Margin % Comparison

For the Biotechnology subindustry, NovaBridge Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovaBridge Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NovaBridge Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where NovaBridge Biosciences's FCF Margin % falls into.


FRA:0VY
30GF Score
NovaBridge Biosciences FRA:0VY
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NovaBridge Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

NovaBridge Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-17.596/0
= %

NovaBridge Biosciences's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
NovaBridge Biosciences (FRA:0VY) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on NovaBridge Biosciences and its competitors. According to the industry distribution chart, NovaBridge Biosciences ranks #999999 out of 958 companies in the Biotechnology industry.
Is NovaBridge Biosciences' FCF Margin % too high?
NovaBridge Biosciences' current FCF Margin % is 0.00%. Based on the distribution chart, NovaBridge Biosciences ranks #999999 out of 958 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, NovaBridge Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does NovaBridge Biosciences' FCF Margin % compare to ELTX and CNTN?
According to the Biotechnology industry distribution chart, NovaBridge Biosciences ranks #999999 out of 958 companies for FCF Margin %. This places NovaBridge Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on NovaBridge Biosciences and its competitors. NovaBridge Biosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovaBridge Biosciences stock overvalued right now?
NovaBridge Biosciences (FRA:0VY) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. NovaBridge Biosciences' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For NovaBridge Biosciences (FRA:0VY), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NovaBridge Biosciences Business Description

Other Exchanges NBP:USA
Address 2440 Research Boulevard, Suite 400, Rockville, MD, USA, 20850
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
30GF Score

Get the complete analysis for FRA:0VY

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.38
Price